4th Quarter - Report
ACG ADVOCACY for GENENTECH INC
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Prescription Drug User Fee Act (PDUFA) Avastin - Use in breast cancer treatment ASP+6 Melanoma Research Foundation Hill event
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS ISRAEL | Dept Asst Sec for Tech Policy, Dept of Commerce |
| IAN P MUSSELMAN | — |
| DAVID J URBAN | Chief of Staff, Senator Arlen Specter |
Copyright/Patent/Trademark CPT
General Patent Reform Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS ISRAEL | — |
| IAN P MUSSELMAN | — |
| DAVID J URBAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.